Meeting of the National Advisory Council for Healthcare Research and Quality, 61765-61766 [2021-24296]

Download as PDF lotter on DSK11XQN23PROD with NOTICES1 Federal Register / Vol. 86, No. 213 / Monday, November 8, 2021 / Notices Description: Initial rate filing: RS 170—NorthernGrid Funding Agreement 2022–2023 to be effective 1/1/2022. Filed Date: 11/2/21. Accession Number: 20211102–5102. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–317–000. Applicants: LS Power Marketing, LLC. Description: § 205(d) Rate Filing: Market-Based Rate Tariff Revisions to be effective 11/3/2021. Filed Date: 11/2/21. Accession Number: 20211102–5121. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–318–000. Applicants: Bolt Energy Marketing, LLC. Description: § 205(d) Rate Filing: Market-Based Rate Tariff Revisions to be effective 11/3/2021. Filed Date: 11/2/21. Accession Number: 20211102–5122. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–319–000. Applicants: Columbia Energy LLC. Description: § 205(d) Rate Filing: Market-Based Rate Tariff Revisions to be effective 11/3/2021. Filed Date: 11/2/21. Accession Number: 20211102–5123. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–320–000. Applicants: LifeEnergy, LLC. Description: § 205(d) Rate Filing: Market-Based Rate Tariff Revisions to be effective 11/3/2021. Filed Date: 11/2/21. Accession Number: 20211102–5124. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–321–000. Applicants: Basin Electric Power Cooperative. Description: § 205(d) Rate Filing: Submission of Revised Wholesale Power Contract FERC Rate Schedule No. 9 to be effective 1/1/2022. Filed Date: 11/2/21. Accession Number: 20211102–5149. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–322–000. Applicants: Startrans IO, LLC. Description: § 205(d) Rate Filing: TRBAA 2022 Update to be effective 1/ 1/2022. Filed Date: 11/2/21. Accession Number: 20211102–5153. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–323–000. Applicants: Exelon Generation Company, LLC. Description: § 205(d) Rate Filing: Nuclear Operating Services Agreements Filing to be effective 12/31/9998. Filed Date: 11/2/21. Accession Number: 20211102–5160. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–324–000. VerDate Sep<11>2014 18:37 Nov 05, 2021 Jkt 256001 Applicants: PJM Interconnection, L.L.C. Description: Tariff Amendment: Notice of Cancellation of Service Agreement Nos. 2274 & 2275 (PJM & AEC NITSA) to be effective 1/1/2022. Filed Date: 11/2/21. Accession Number: 20211102–5164. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–325–000. Applicants: Calvert Cliffs Nuclear Power Plant, LLC. Description: § 205(d) Rate Filing: Certificate of Concurrence for Nuclear Operating Services Agreement to be effective 12/31/9998. Filed Date: 11/2/21. Accession Number: 20211102–5167. Comment Date: 5 p.m. ET 11/23/21. Docket Numbers: ER22–326–000. Applicants: Exelon FitzPatrick, LLC. Description: § 205(d) Rate Filing: Certificate of Concurrence for Nuclear Operating Services Agreement to be effective 12/31/9998. Filed Date: 11/2/21. Accession Number: 20211102–5173. Comment Date: 5 p.m. ET 11/23/21. Take notice that the Commission received the following electric securities filings: Docket Numbers: ES22–18–000. Applicants: Portland General Electric Company. Description: Application Under Section 204 of the Federal Power Act for Authorization to Issue Securities of Portland General Electric Company. Filed Date: 10/29/21. Accession Number: 20211029–5392. Comment Date: 5 p.m. ET 11/19/21. Docket Numbers: ES22–19–000; ES22–20–000; ES22–21–000; ES22–22– 000. Applicants: Entergy Arkansas, LLC, Entergy Mississippi, LLC, Entergy Texas, Inc., System Energy Resources, Inc. Description: Application Under Section 204 of the Federal Power Act for Authorization to Issue Securities of Entergy Arkansas, LLC, et al. Filed Date: 10/29/21. Accession Number: 20211029–5393. Comment Date: 5 p.m. ET 11/19/21. The filings are accessible in the Commission’s eLibrary system (https:// elibrary.ferc.gov/idmws/search/fercgen search.asp) by querying the docket number. Any person desiring to intervene or protest in any of the above proceedings must file in accordance with Rules 211 and 214 of the Commission’s Regulations (18 CFR 385.211 and 385.214) on or before 5:00 p.m. Eastern time on the specified comment date. PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 61765 Protests may be considered, but intervention is necessary to become a party to the proceeding. eFiling is encouraged. More detailed information relating to filing requirements, interventions, protests, service, and qualifying facilities filings can be found at: https://www.ferc.gov/ docs-filing/efiling/filing-req.pdf. For other information, call (866) 208–3676 (toll free). For TTY, call (202) 502–8659. Dated: November 02, 2021. Debbie-Anne A. Reese, Deputy Secretary. [FR Doc. 2021–24354 Filed 11–5–21; 8:45 am] BILLING CODE 6717–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services. ACTION: Notice of public meeting. AGENCY: This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Wednesday, November 17, 2021, from 10:00 a.m. to 3:00 p.m. ADDRESSES: The meeting will be held virtually. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427– 1456. For press-related information, please contact Bruce Seeman at (301) 427–1998 or Bruce.Seeman@ AHRQ.hhs.gov. Closed captioning will be provided during the meeting. If another reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Monday, November 8, 2021. The agenda, roster, and minutes will be available from Ms. Heather Phelps, Committee Management Officer, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland, 20857. Ms. Phelps’ phone number is (301) 427–1128. SUPPLEMENTARY INFORMATION: SUMMARY: E:\FR\FM\08NON1.SGM 08NON1 61766 Federal Register / Vol. 86, No. 213 / Monday, November 8, 2021 / Notices I. Purpose In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App., this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality (the Council). The Council is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Wednesday, November 17, 2021, the Council meeting will convene at 10:00 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting will begin with an introduction of new NAC members and then an update on AHRQ’s Subcommittee of the National Advisory Council (SNAC) on Healthcare Quality Measurement. The agenda will also include a discussion on primary care. The meeting will adjourn at 3:00 p.m. The meeting is open to the public. For information regarding how to access the meeting as well as other meeting details, including information on how to make a public comment, please go to https:// www.ahrq.gov/news/events/nac/. The final agenda will be available on the AHRQ website no later than Thursday, November 11, 2021. Dated: November 2, 2021. Marquita Cullom, Associate Director. [FR Doc. 2021–24296 Filed 11–5–21; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Council for the Elimination of Tuberculosis Meeting (ACET). This meeting is open to the public and limited to 1,000 audio and web conference lines. Time will be available for public comment. DATES: The meeting will be held on December 14, 2021, from 10:00 a.m. to 3:45 p.m., EST, and December 15, 2021, from 10:00 a.m. to 12:00 p.m., EST. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. In the subject line, please note ATTN: Staci Morris for ACET Public Comment. The public comment should include your name, affiliation, and email address. Comments must be received on or before December 13, 2021. ADDRESSES: The web conference access is: https://cdc.zoomgov.com/j/ 1612312595?pwd=WnhzbDdEZGJIQXc 1UkhoN2sxU05IUT09. Passcode: H&0uhKFm. Webinar ID: 161 231 2595. The teleconference access is noted as follows: Telephone number: 1–669–254–5252; and the passcode is 49252654. FOR FURTHER INFORMATION CONTACT: Staci Morris, Committee Management Specialist, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), CDC, 1600 Clifton Road NE, Mailstop US8–6, Atlanta, Georgia 30329–4027; Telephone: (404) 718– 7479; Email: nchhstppolicy@cdc.gov. (In the subject line, please note ATTN: Staci Morris for ACET Public Comment). SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 SUPPLEMENTARY INFORMATION: Purpose: The Council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis (TB). Specifically, the Council makes VerDate Sep<11>2014 18:37 Nov 05, 2021 Jkt 256001 PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Considered: The agenda will include discussions on: (1) Study 31 Regimen Guidance; (2) TB Epidemiologic Studies Consortium; (3) Latent Tuberculosis Infection (LTBI) Campaign; (4) NCHHSTP and Division of Tuberculosis Elimination Equity Activities; (5) Electronic Directly Observed Therapy (eDOT) Study; and (6) Multi-State TB Outbreak Associated with Bone Allograft Surgery. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–24321 Filed 11–5–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2021–0098] Advisory Committee on Immunization Practices (ACIP); Amended Notice of Meeting Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: https://www.cdc.gov/ vaccines/acip/. SUMMARY: E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 86, Number 213 (Monday, November 8, 2021)]
[Notices]
[Pages 61765-61766]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24296]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department 
of Health and Human Services.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the National Advisory 
Council for Healthcare Research and Quality.

DATES: The meeting will be held on Wednesday, November 17, 2021, from 
10:00 a.m. to 3:00 p.m.

ADDRESSES: The meeting will be held virtually.

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management 
Official, at the Agency for Healthcare Research and Quality, 5600 
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427-
1456. For press-related information, please contact Bruce Seeman at 
(301) 427-1998 or [email protected]. Closed captioning will be 
provided during the meeting. If another reasonable accommodation for a 
disability is needed, please contact the Food and Drug Administration 
(FDA) Office of Equal Employment Opportunity and Diversity Management 
on (301) 827-4840, no later than Monday, November 8, 2021. The agenda, 
roster, and minutes will be available from Ms. Heather Phelps, 
Committee Management Officer, Agency for Healthcare Research and 
Quality, 5600 Fishers Lane, Rockville, Maryland, 20857. Ms. Phelps' 
phone number is (301) 427-1128.

SUPPLEMENTARY INFORMATION:

[[Page 61766]]

I. Purpose

    In accordance with section 10(a) of the Federal Advisory Committee 
Act, 5 U.S.C. App., this notice announces a meeting of the National 
Advisory Council for Healthcare Research and Quality (the Council). The 
Council is authorized by Section 941 of the Public Health Service Act, 
42 U.S.C. 299c. In accordance with its statutory mandate, the Council 
is to advise the Secretary of the Department of Health and Human 
Services and the Director of AHRQ on matters related to AHRQ's conduct 
of its mission including providing guidance on (A) priorities for 
health care research, (B) the field of health care research including 
training needs and information dissemination on health care quality and 
(C) the role of the Agency in light of private sector activity and 
opportunities for public private partnerships. The Council is composed 
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.

II. Agenda

    On Wednesday, November 17, 2021, the Council meeting will convene 
at 10:00 a.m., with the call to order by the Council Chair and approval 
of previous Council summary notes. The meeting will begin with an 
introduction of new NAC members and then an update on AHRQ's 
Subcommittee of the National Advisory Council (SNAC) on Healthcare 
Quality Measurement. The agenda will also include a discussion on 
primary care. The meeting will adjourn at 3:00 p.m.
    The meeting is open to the public. For information regarding how to 
access the meeting as well as other meeting details, including 
information on how to make a public comment, please go to https://www.ahrq.gov/news/events/nac/. The final agenda will be available on 
the AHRQ website no later than Thursday, November 11, 2021.

    Dated: November 2, 2021.
Marquita Cullom,
Associate Director.
[FR Doc. 2021-24296 Filed 11-5-21; 8:45 am]
BILLING CODE 4160-90-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.